Literature DB >> 23377670

Synergistic effect between lipoprotein lipase and apolipoprotein C3 genes in determining the severity of coronary artery disease.

Tarek A Abd-El-Aziz1, Randa H Mohamed, Amal S El-Shal.   

Abstract

A number of genetic variants have been identified in the lipoprotein lipase (LPL) gene. We aimed to investigate the possible associations between LPL gene and apolipoprotein C3 (APOC3) gene polymorphisms with coronary artery disease (CAD) and its severity, as well as the interaction between these polymorphisms and classical risk factors. The HindIII variant of LPL and APOC3 were genotyped in 156 CAD patients and 154 subjects as a control group. We found that the odds ratio (OR) estimating the effect of joint exposure to H2H2 genotype of LPL and S2S2 genotype of APOC3 was significantly higher than the OR estimating the effect of each factor in the absence of the other. The present study points to a synergistic interaction between H2H2 genotype of LPL gene and S2S2 genotype of APOC3 gene that leads to increased severity of CAD. Smoking, low HDL, and diabetes increased the severity of CAD in patients carrying these risky genotypes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377670     DOI: 10.1007/s12265-013-9446-3

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  25 in total

1.  Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism.

Authors:  Alex Bobik
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

2.  Plasma and vessel wall lipoprotein lipase have different roles in atherosclerosis.

Authors:  S M Clee; N Bissada; F Miao; L Miao; A D Marais; H E Henderson; P Steures; J McManus; B McManus; R C LeBoeuf; J J Kastelein; M R Hayden
Journal:  J Lipid Res       Date:  2000-04       Impact factor: 5.922

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Association of two genetic variations of lipoprotein lipase, S447X and Hind III, with coronary artery disease and hypertriglyceridemia.

Authors:  Daria Pasalić; Goran Ferencak; Branka Grsković; Mihajlo Sesto; Ana Stavljenić-Rukavina
Journal:  Coll Antropol       Date:  2006-09

5.  Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis.

Authors:  H H Wittrup; A Tybjaerg-Hansen; B G Nordestgaard
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

6.  Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.

Authors:  J M Ordovas; F Civeira; J Genest; S Craig; A H Robbins; T Meade; M Pocovi; P M Frossard; U Masharani; P W Wilson
Journal:  Atherosclerosis       Date:  1991-03       Impact factor: 5.162

7.  Plasma leptin and prognosis in patients with established coronary atherosclerosis.

Authors:  Robert Wolk; Peter Berger; Ryan J Lennon; Emmanouil S Brilakis; Bruce D Johnson; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

8.  Detection of three separate DNA polymorphisms in the human lipoprotein lipase gene by gene amplification and restriction endonuclease digestion.

Authors:  T Gotoda; N Yamada; T Murase; H Shimano; M Shimada; K Harada; M Kawamura; K Kozaki; Y Yazaki
Journal:  J Lipid Res       Date:  1992-07       Impact factor: 5.922

Review 9.  Molecular pathobiology of the human lipoprotein lipase gene.

Authors:  V Murthy; P Julien; C Gagne
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

10.  Relationships between the metabolism of high-density and very-low-density lipoproteins in man: studies of apolipoprotein kinetics and adipose tissue lipoprotein lipase activity.

Authors:  P Magill; S N Rao; N E Miller; A Nicoll; J Brunzell; J St Hilaire; B Lewis
Journal:  Eur J Clin Invest       Date:  1982-04       Impact factor: 4.686

View more
  2 in total

1.  Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis.

Authors:  Jing-Zhan Zhang; Xiang Xie; Yi-Tong Ma; Ying-Ying Zheng; Yi-Ning Yang; Xiao-Mei Li; Zhen-Yan Fu; Chuan-Fang Dai; Ming-Ming Zhang; Guo-Ting Yin; Fen Liu; Bang-Dang Chen; Min-Tao Gai
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

2.  Associations between LPL gene polymorphisms and coronary artery disease: evidence based on an updated and cumulative meta-analysis.

Authors:  Wen-Qi Ma; Ying Wang; Xi-Qiong Han; Yi Zhu; Nai-Feng Liu
Journal:  Biosci Rep       Date:  2018-02-19       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.